Match Document Document Title
US20150183703 SYNTHESIS OF DIACIDS  
The invention relates to a process for preparing a dicarboxylic acid comprising the steps: (a) heating a lactone in the presence of a first catalyst system to produce an alkenoic acid; and (b)...
US20080268123 Onion Flavoured Compounds and Use  
The invention relates to compounds of O-alkylated sulphur-containing amino acids or peptides that provide an onion flavour to consumables and flavour compositions, and to consumables and flavour...
US20120010291 CREATINE Beta-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE  
Disclosed are creatine β-alaninate, compositions and formulations containing same, and methods of use therefor.
US20120004455 SOLID TEREPHTHALIC ACID COMPOSITION  
A solid terephthalic acid composition and a process for producing terephthalic acid from para-xylene. The process comprises forming a mixture comprising the para-xylene, a solvent, a bromine...
US20140155653 AN IMPROVED PROCESS FOR CATALYTIC DEHYDRATION OF LACTIC ACID TO ACRYLIC ACID  
Disclosed herein is an improved process for the catalytic dehydration of lactic acid to acrylic acid. More particularly, the present invention discloses catalytic dehydration of lactic acid to...
US20130157034 METHOD FOR CHEMICAL MODIFICATION OF A GRAPHENE EDGE, GRAPHENE WITH A CHEMICALLY MODIFIED EDGE AND DEVICES INCLUDING THE GRAPHENE  
A method for chemical modification of graphene includes dry etching graphene to provide an etched graphene; and introducing a functional group at an edge of the etched graphene. Also disclosed is...
US20080300309 Creatine Hydroxycitric Acids Salts and Methods for their Production and use in Individuals  
Methods of production for Tricreatine Hydroxycitrate are disclosed. Tricreatine hydroxycitrate can be used as supplemental dietary ingredient for the purposes of reducing adiposity, suppression of...
US20070054960 Sertraline acid addition salt, its preparation and its use in the preparation of sertraline hydrochloride form II  
The present invention relates to novel acid addition salts of sertraline, their preparation and their use in the preparation of crystalline Form-II of Sertraline hydrochloride.
US20100310467 COMPOSITION AND METHOD FOR GENERATING A METABOLIC PROFILE USING 13C-MR DETECTION  
The invention relates to a method of 13C-MR detection using an imaging medium comprising hyperpolarised 13C-fumarate and imaging media comprising hyperpolarised 13C-fumarate for use in said method.
US20080233606 USE OF RAMAN SPECTROSCOPY IN ENZYME ACTIVITY ASSAYS  
Provided herein are assays for detecting enzyme activity using Raman Spectroscopy.
US20130231504 METHOD FOR PRODUCING BIORESOURCED PROPIONIC ACID FROM GLYCEROL  
A method for producing bioresourced propionic acid from glycerol. Also, a composition comprising more than 85 mass % of bioresourced propionic acid, and to the use of the propionic acid obtained...
US20110319641 TREPROSTINIL PRODUCTION  
The present invention is directed to a novel method for preparing a synthetic intermediate for treprostinil via a stereoselective alkyne addition reaction. Also described are methods of preparing...
US20110257361 ALKYL BENZENE TETRACARBOXYLIC DIANHYDRIDE, MANUFACTURING METHOD THEREOF, POLYIMIDE, AND APPLICATION THEREOF  
Disclosed is a 5-alkyl-1,2,3,4-benzene tetracarboxylic-1:2,3:4-dianhydride which is represented by the general formula (1) and has excellent solubility with respect to various organic solvents....
US20120101296 METHOD FOR PREPARING TRICYCLIC DERIVATIVES  
The present invention relates to a method for preparing a tricyclic derivative, and more particulary, to a method for preparing a tricyclic derivative inetermediate with high yield and purity, the...
US20090162280 DETECTING SOLUBLE A-BETA  
Agents, methods, and kits for qualitatively or quantitatively determining the presence of soluble A-beta in source of A-beta are provided, wherein the agents comprise the compound of formula III...
US20060089512 Method for reducing mehq content in acrylic acid  
The invention relates to the reduction of the content of MEHQ (methoxyhydroquinone) of acrylic acid or its salts by means of continuous adsorption on activated carbon. In particular, MEHQ is...
US20050250818 Ortho substituted aryl or heteroaryl amide compounds  
This invention provides a compound of the formula (I): wherein X represents a carbon atom or the like: Y represents imino, or the like: Z represents a hydrogen atom or the like: R1 represents an...
US20110172461 Polymer Recycling Methods Employing Catalytic Transfer Hydrogenation and Base Cleavage Reactions  
Methods of recycling a post-consumer polymer material comprise depolymerizing the polymer material by heating the polymer material in the presence of a hydrogen donor material and a strong base...
US20090105288 CARBON LINKED MODULATORS OF gamma-SECRETASE  
The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, R1, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula...
US20110257379 LEAD COMPOUND OF ANTI-HYPERTENSIVE DRUG AND METHOD FOR SCREENING THE SAME  
A system for screening a small molecule library with 250,000 molecules to find out a compound of an anti-hypertensive drug aiming at human Angiotensin II type IA receptor is provided. The system...
US20110190368 Organosulfur Compounds, a Method of Making Organosulfur Compounds and their Use for Inhibiting the Growth of Tumour Cells  
Organosulfur compounds of the general formula (2) are described, wherein R1 and R2 are linear or branched C1-C5 alkyl; linear or branched C1-C5 alkenyl with the proviso that R1 is not prop-1-enyl...
US20140179640 TOPICAL COMPOSITIONS FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS  
The present invention relates to pharmaceutical compositions and methods useful for the treatment of dermatological disorders, and in particular acne vulgaris and skin pigmentation disorders....
US20140364500 URSOLIC ACID SALTS FOR TREATING DIABETES AND OBESITY  
The present invention relates to compounds having the following structure: wherein R is H or OH and X+ is protonated metformin, protonated arginine, protonated lysine and protonated meglumine. The...
US20050059610 Glutamine for use in treating injury  
A method of treating a problem relating to tissue metabolism by administering to a patient in need a single dose of glutamine in a pharmaceutically acceptable carrier. Also provided is glutamine...
US20100297756 MEANS FOR DELIVERY OF NUCLEIC ACIDS ACTIVE FOR GENE SILENCING USING SYNTHETIC POLYMERS  
The invention relates to a composition useful as transfection agent, comprising polyamines modified by aromatic amino acids and small double-strand or single-strand RNA active for RNA interference.
US20110189740 CATALYST FOR THE DECOMPOSITION OF LIGNIN, METHOD FOR THE PREPARATION OF ALCOHOLS AND ORGANIC ACIDS, METHOD FOR THE PREPARATION OF LIGNIN-DECOMPOSITION PRODUCTS, CATALYST FOR THE DECOMPOSITION OF AROMATIC HYDROCARBONS, METHOD FOR RELEASING HYDROGEN IONS, AS WELL AS PORPHYRIN  
Herein provided are a lignin-decomposition catalyst and an aromatic hydrocarbon-decomposition catalyst, which contain a porphyrin. Alcohols and organic acids can be isolated or separated from...
US20120009121 PSMA-TARGETING COMPOUNDS AND USES THEREOF  
Prostate-specific membrane antigen (PSMA) targeting compounds are described. Uses of the compounds for imaging, therapy, cell sorting, and tumor mapping are also described.
US20100150851 ANIONIC-CATIONIC COMPLEXES AS CONDITIONING AGENTS  
Novel compositions comprising anionic-cationic complexes as conditioning agents for use in products that improve the appearance and feel of skin and hair are well known. This invention describes...
US20090098066 Substituted bicyclo [2.2.2] oct/5-ene compounds and their use as cooling agents  
Used as cooling agents are the compounds of 1/7-isopropyl-4/5-methyl-bicyclo[2.2.2]oct-5-ene derivatives of the formula (I) wherein R1 and R2 are independently hydrogen, hydroxyl, hydroxymethyl,...
US20130237573 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS  
A mGlu2/3 receptor antagonist of the formula: its uses, and methods for its preparation are described.
US20120129902 4-SUBSTITUTED-3-PHENYLSULFANYLMETHYL-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS  
A mGlu2/3 receptor antagonist of the formula: its uses, and methods for its preparation are described.
US20080227638 Use of abscisic acid to enhance growth control  
This invention describes the use of S-(+)-abscisic acid (ABA) or its salts in combination with gibberellin biosynthesis inhibitors to improve the performance of gibberellin synthesis inhibitors,...
US20120004365 Aqueous Polymerization of Fluorinated Monomer Using a Mixture of Fluoropolyether Acids or Salts  
A composition comprising a mixture of fluoropolyether acids or salts having a number average value of about 800 to about 2500 g/mol. The amount of fluoropolyether acids or salt in the mixture...
US20110251407 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE ORGANIC CARBOXYLIC ACID  
The present invention is a simple method, in which a specific amount of alkali is added to an enantiomeric mixture of an optically active organic carboxylic acid where enantiomers are present in a...
US20150030670 AMINOACID LIPIDS  
The present invention is directed to a new class of lipids, more specifically ether-lipids having a polar headgroup, as well as vesicles comprising these lipids, methods of their preparation as...
US20090270652 PROCESS FOR TRANSFERRING HEAT TO A LIQUID COMPRISING DISSOLVED MONOMERIC ACRYLIC ACID, MICHAEL ACRYLIC ACID OLIGOMERS AND ACRYLIC ACID POLYMER  
A process for transferring heat to a liquid F comprising dissolved monomeric acrylic acid, Michael acrylic acid oligomers, and acrylic acid polymer with the aid of an indirect heat exchanger to...
US20130210828 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPEs)  
The present disclosure provides novel poly(phenylene ethynylene) (PPE) compounds, methods for synthesizing these compounds, and materials and substances incorporating these compounds. The various...
US20140058131 Process For Recovering Permanganate Reducing Compounds From An Acetic Acid Production Process  
This invention relates to processes for producing acetic acid and, in particular, to improved processes for recovering permanganate reducing compounds formed during the carbonylation of methanol...
US20090325893 DOXORUBICIN ADJUVANTS TO REDUCE TOXICITY AND METHODS FOR USING THE SAME  
Methods are provided for using doxorubicin active agents in which reduced host toxicity is observed. Aspects of the methods including administering to a subject an effective amount of a...
US20150126771 MULTI-PHASE REACTOR SYSTEM WITH SLINGER LIQUID REFLUX DISTRIBUTOR  
A multi-phase reactor system for performing multi-phase reactions is disclosed. The reactor system includes a reaction vessel having a slinger device (100) mounted on a centrally positioned...
US20080132619 Phosphorus-Containing Flame Retardant for Thermoplastic Polymers  
A flame retarded thermoplastic polymer composition comprising a thermoplastic polymer and a metal salt of phosphinic acid possessing a desired degree of volatility.
US20070191633 Mixed anionic surfactant composition for oil recovery  
A composition for recovering oil from subterranean formation by injecting an aqueous fluid containing from about 0.05 to about 2.0% by weight of a bi-functional surfactant or a mixture of...
US20130289302 METHODS AND SYSTEMS FOR GENERATING POLYOLS  
Disclosed are methods for generating propylene glycol, ethylene glycol and other polyols, diols, ketones, aldehydes, carboxylic acids and alcohols from biomass using hydrogen produced from the...
US20120283451 PROCESS FOR THE PREPARATION OF F-SERIES PROSTAGLANDINS  
A process for the synthesis and purification of F-series prostaglandin compounds and synthetic intermediates used to prepare them. The synthetic intermediates are solid and may be purified by...
US20050203180 Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease  
The present invention relates to cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease, which have excellent effect on enhancing the learning and...
US20120190091 LIQUID-PHASE AND VAPOR-PHASE DEHYDRATION OF ORGANIC / WATER SOLUTIONS  
Disclosed herein are processes for removing water from organic compounds, especially polar compounds such as alcohols. The processes include a membrane-based dehydration step, using a membrane...
US20090069597 Method for concentrating an aqueous ammonium carbamate stream  
The invention relates to a method for concentrating an aqueous ammonium carbamate stream, which has been formed in a process for the preparation of urea, has a pressure between 0.20 MPa and 0.9...
US20080015385 Preparation of (S)-pregabalin-nitrile  
Provided are processes for the preparation of (3S)-cyano-5-methylhexanoic acid, an intermediate in the synthesis of (S)-pregabalin.
US20080255173 Novel Specific Caspase-10 Inhibitors  
The invention relates to compounds of the general formula (I), and to their use as caspase-10 inhibitors, especially for the treatment of diabetic retinopathy.
US20140135400 NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR  
The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity....